Skip to main content
OpenTrials

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,773 public trials 496 recruiting studies
Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

A Study of Vemurafenib Adjuvant Therapy in Participants With Surgically Resected Cutaneous BRAF-Mutant Melanoma

NCT01667419

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • UCLA Department of Medicine; Division of Hematology / Oncology California City, California, United States
  • Kaiser Permanente - Hayward Hayward, California, United States
  • UCLA Hematology Oncology - Irvine Irvine, California, United States
View all 207 locations
View Trial Details
Completed

A Study of Intratumoral CAVATAK™ in Patients With Stage IIIc and Stage IV Malignant Melanoma (VLA-007 CALM )

NCT01227551

Conditions
Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations
  • Moores UCSD Cancer Center La Jolla, California, United States
  • St Mary's Medical Center San Francisco, California, United States
  • Mount Sinai Medical Center Miami Beach, Florida, United States
  • Rush University Medical Center Chicago, Illinois, United States
View Trial Details
Completed

Investigate Safety, Pharmacokinetics and Pharmacodynamics of GSK2118436 & GSK1120212

NCT01072175

Conditions
Cancer, Melanoma, Neoplasms, +10 more
Locations
  • Novartis Investigative Site Los Angeles, California, United States
  • Novartis Investigative Site San Francisco, California, United States
  • Novartis Investigative Site Aurora, Colorado, United States
  • Novartis Investigative Site New Haven, Connecticut, United States
View all 15 locations
View Trial Details

Related conditions